When will the Ellipse SCS platform be available?

"Good things take time, great things take a little longer."

We are feverishly working with our manufacturing partners to bring Ellipse technology to market as soon as possible. The U.S. Food and Drug Administration has granted our StimuLux technology their Breakthrough Device Designation which expedites our regulatory review. We anticipate U.S. market entry in 2027.